AI governance becomes critical for pharma as the industry integrates artificial intelligence into drug discovery, clinical trials and regulatory processes.
AI-powered biomarker discovery gains momentum as a transformative approach to identify disease indicators, personalize treatments and improve trial success.
AI enables smarter formulation development by optimizing drug delivery, stability and patient adherence through advanced machine learning and predictive models.
AI strengthens drug repurposing strategies by identifying new therapeutic uses for existing medications, reducing the time and cost of drug development.
GenAI is changing pharma research workflows by accelerating drug discovery, optimizing clinical trials and enhancing data analysis for better outcomes.
